Contra Fusion Pharmace
13F holders, Q4 2025 (December 31)1holders −1
0new positions
1sold out
$0.00avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding Contra Fusion Pharmace in their 13F filings, down 1 from Q3 2025. 0 opened new positions and 1 sold out. The largest holder was GAMMA Investing LLC ($0).
- Company
- Contra Fusion Pharmace
- Filed as
- FUSION PHARMACEUTICALS INC CVR from 36118A100 (Q4 2025)
- CUSIP
- 361CVR012
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 50,000 shares sold, net −50,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| GAMMA Investing LLC | 0.00% | No change | 14 | $0 |
"% of holder's portfolio" is CONTRA FUSION PHARMACE's weight in each manager's 13F, not the share of Contra Fusion Pharmace the manager owns.